Member Area

Farmavita.Net - Pharmaceutical Licensing Network

Saturday
May 25th
Home arrow Farmavita.Net Journal arrow Cefuroxime Axetil
Cefuroxime Axetil Print E-mail
Life Sciences - Life Science Article
Written by R.Margret Chandira   
Monday, 25 May 2009

shot_of_pills_by_sparktography_from_flickr.com.jpg

FORMULATION AND EVALUATION OF FLOATING TABLETS OF CEFUROXIME AXETIL

The aim of the present work was to design and development of hydrodynamically balanced tablet of cefuroxime axetil to enhance the bioavailability and therapeutic efficacy of the drug. Cefuroxime axetil is classified as a second-generation cephalosporin antibiotic and beta lactum antibiotics based on spectrum activity. Tablets are prepared by the direct compression technique by using HPMC K4M and mannitol as polymers along with sodium bi carbonate as gas generating agent. Formulation were evaluated for in vitro byoyancy and drug release study using up dissolation apparatus using 0.1N Hcl as a medium.The result indicate that floating tablets of dissolation cefuroxime axetil containg 45mg HPMC K4M provides a better option for control release action and improved bioavailability.

The whole 8 pages article is available for download at Downloads section of Farmavita.Net

 

The design of oral controlled drug delivery systems (DDS) should be primarily aimed to achieve more predictable and bioavailability. Approximately 50% of the drug delivery systems available in the market are oral DDS and these systems have more advantages due to patient acceptance and ease to administration. Gastric retention drug delivery systems can be retained in the stomach for a long time. Such retention systems are important for drugs that are degraded in intestine or for drugs like antacids or certain antibiotics.

Cefuroxime axetil is classified as a second generation cephalosporin antibiotic and cefuroxime axetil beta lectum antibiotics based on spectrum of activity. In the present work by developing hydrodynamically balanced system or floating drug delivery system which increases the gastric residence time, decreases the diffusion distance and allow more of antibiotic to penetrate through the gastric mucus layer and act locally at the infectious site. The present study outlines a systemic approach for design and development of hydrodynamically balanced tablets cefuroxime axetil to enhance the bioavailability and therapeutic efficacy of the drug.

The whole 8 pages article is available for download at Downloads section of Farmavita.Net

Comments
Add New Search RSS
Write comment
Name:
Email:
 
Website:
Title:
 
Please input the anti-spam code that you can read in the image.

3.26 Copyright (C) 2008 Compojoom.com / Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."

Read also at Pharmaceutical Licensing Network
Related News
Newer news items
Related Items
Farmavita.Net - The Pharmaceutical Licensing Network




Reddit!Del.icio.us!Google!Live!Facebook!Slashdot!Netscape!Technorati!StumbleUpon!Newsvine!Furl!Blogmarks!Yahoo!Ma.gnolia!FeedMeLinks!Free social bookmarking plugins and extensions for Joomla! websites!
 
< Prev   Next >
Advertisement

Featured Partners

 
logo_kvadrat_150x150.jpg    
lcm-150x150.jpg  
150-150-static.gif
apacma13_150x150_banner.gif  
  doctors20150x1501.png
bals137_150x150.gif
bals138_150x150.jpg
ch-150x150-an.gif 
pharmaccess13a_150x150.gif 

Login to Farmavita.Net

membership is FREE

Follow us on:




Join our LinkedIn Group

BabelFish Translator




Click Flag for Translation

Who's Online

We have 11 guests online

Farmavita.Net RSS News


Reports

rbdl0002_innovations-in-inj.gif 

Events

150-150-static.gif

Reports

rbhc0264_privatehealthcare.gif 

REPORTS

farmavita_research-store.gif